BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|May 1, 2003
- Volume 0 0
May 2003: Rx Image Two
Advertisement
function showAnswer() {document.getElementById("answer").style.display = 'block';document.getElementById("link").style.display = 'none';}
It is par for the course that pharmacists receive prescriptions that are puzzling. Pharmacist Dilesh Patel of Hillcrest Pharmacy in Pennsauken, NJ, is used to solving mind-boggling scripts. In this particular case, he had to use all of his deciphering capabilities to figure out the prescription. What would your guess be?
Articles in this issue
over 23 years ago
Compounding terbutaline solutionover 23 years ago
Contraceptive Sponge Makes Comebackover 23 years ago
Avlimil Is a Woman's Answer to Viagraover 23 years ago
Stormy Weather Provokes Asthmaover 23 years ago
Allergies Affect the Bottom Lineover 23 years ago
Treat the GERD and the Asthma Resolvesover 23 years ago
Think Before You Light Upover 23 years ago
Statins and High Blood Pressureover 23 years ago
Age a Nonissue for Lowering Cholesterolover 23 years ago
Can Cholesterol Drugs Help MS?Advertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
2
Statin Myths: Why Patients Avoid Cholesterol-Lowering Therapy
3
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
4
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
5